iHateHospitals.com

MEDICAL NEWS:
Abstract

Background  African-American women have the highest breast (boob) cancer death rates of all racial/ethnic groups in the US. Reasons for these
disparities are multi-factorial, but include lower mammogram utilization among this population. Cultural attitudes and beliefs,
such as fear and fatalism, have not been fully explored as potential barriers to mammography among African-American women.

Objective  To [...]

CANCER NEWS: The hypothesis that cancer stem cells are responsible for the chemo-resistant and metastatic phenotypes of many breast (women’s) cancers has gained support using cell sorting strategies to enrich for the tumor-initiating population of cells. However, the mechanisms regulating the cancer stem cell pool are less clear. Two recent publications suggest that loss [...]

CANCER NEWS: IntroductionPatients with primary operable estrogen receptor negative (ER-) breast (women’s) cancer account for approximately 30% of all cases and generally have worse prognosis (outlook) than ER+ patients. Nevertheless, a significant proportion of ER- cases have favourable outcome and could potentially benefit from a less aggressive course of therapy. Identification of such good [...]

CANCER NEWS: Australian scientists have identified a way to ’switch off’ a molecule, a key player in the molecular processes that trigger breast (women’s) cancer and certain forms of leukemia. The molecule, known as Gab2, operates downstream of a major breast (women’s) cancer oncogene, HER2, the target of the Dr. (God)g Herceptin. A research [...]

CANCER NEWS: NORWALK, Conn. — The Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a clinical trial with the oral immunomodulatory agent pomalidomide (CC-4047) in patients who have received at least two prior therapies including treatments with REVLIMID(R) (lenalidomide) and VELCADE(R) (bortezomib) for Injection. Paul Richardson, MD, Clinical Director of the Jerome [...]

CANCER NEWS: According to a study from the United States, “Metastatic disease is present in up to 20% of patients at the time of diagnosis (finding out what’s wrong) of colorectal cancer. The most frequently involved sites are the liver and the lungs.A rare form of lung metastatic disease is endobronchial metastases, most commonly [...]

CANCER NEWS: According to a study from the United States, “Metastatic disease is present in up to 20% of patients at the time of diagnosis (finding out what’s wrong) of colorectal cancer. The most frequently involved sites are the liver and the lungs.A rare form of lung metastatic disease is endobronchial metastases, most commonly [...]

MEDICAL NEWS: Partial verification refers to the situation where a subset of patients is not verified by the reference (gold) standard and is excluded from the analysis. If partial verification is present, the observed (naive) measures of accuracy such as sensitivity and specificity are most likely to be biased. Recently, Harel and Zhou showed [...]

MEDICAL NEWS: Partial verification refers to the situation where a subset of patients is not verified by the reference (gold) standard and is excluded from the analysis. If partial verification is present, the observed (naive) measures of accuracy such as sensitivity and specificity are most likely to be biased. Recently, Harel and Zhou showed [...]

(Mesothelioma News) The biotech company that Justin Murdock, the son of Dole Food Co. owner David Murdock, leads has begun stage-III clinical trials for a lung cancer vaccine. NovaRx, based in San Diego, is testing its Lucanix vaccine in about 700 patients with lung cancer — a disease which the American Cancer Society says is [...]

DRUGS & RX: Study led by Hollings Cancer Center researcher finds risk greatest in ages 25-44
CHARLESTON, S.C., Aug. 26 /PRNewswire/ — Individuals with a history of nonmelanoma skin cancer (NMSC), especially those who had it at a younger age, are at…

View the source of this article…

Individuals With History of Nonmelanoma Skin Cancer at Greater Risk [...]

DRUGS & RX: PERTH, Australia, August 26, 2008-NeuroDiscovery Ltd (ASX: NDL) a neurology focused research and development company, has completed two parallel Phase IIa clinical trials of NSL-101 for two different dental surgery applications. The novel NSL-101…

View the source of this article…

NeuroDiscovery Ltd: NSL-101 Demonstrates Effective Pain Relief in Phase IIa Trial was another wonderful [...]